Biogen (BIIB) said Monday it has signed a 15-year lease for its new global headquarters at Kendall Common in Cambridge, Massachusetts.
The company said it intends to shift its Cambridge-based employees to the new facility when it opens in 2028.
Biogen said it will integrate its research and development and technical operations teams alongside its global and North American commercial organizations into a co-located innovation hub, adding that the lease deal is with a new joint venture collaboration between MIT Investment Management and Blackstone (BX) Real Estate portfolio company BioMed Realty, which is constructing the new building.
Price: 141.36, Change: +0.46, Percent Change: +0.33
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。